Blueberries Medical Corp
CNSX:BBM
Operating Margin
Blueberries Medical Corp
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
CA |
B
|
Blueberries Medical Corp
CNSX:BBM
|
2m CAD |
-187%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
687.1B USD |
40%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.5B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.9B CHF |
33%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
183.7B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
162.7B GBP |
24%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
193.7B USD |
34%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
117.5B EUR |
22%
|
Blueberries Medical Corp
Glance View
Blueberries Medical Corp. engages in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-04-09. The firm is engaged in the cultivation and development of medicinal cannabis and related products. The firm is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Blueberries Medical Corp's most recent financial statements, the company has Operating Margin of -187.1%.